HOOD vs. UTHR
HOOD (Robinhood Markets, Inc.) and UTHR (United Therapeutics Corporation) are both stocks. HOOD operates in Capital Markets (Financial Services), while UTHR operates in Biotechnology (Healthcare). Over the past 3 years, HOOD returned 108.29%/yr vs 33.59%/yr for UTHR. At a 0.15 correlation, their price movements are largely independent.
Performance
HOOD vs. UTHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HOOD achieves a -24.81% return, which is significantly lower than UTHR's 11.79% return.
HOOD
- 1D
- 3.12%
- 1M
- 10.40%
- YTD
- -24.81%
- 6M
- -37.67%
- 1Y
- 13.57%
- 3Y*
- 108.29%
- 5Y*
- —
- 10Y*
- —
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
HOOD vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
HOOD Robinhood Markets, Inc. | -24.81% | 203.54% | 192.46% | 56.51% | -54.17% | -53.26% |
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 60.46% | -20.93% | 28.70% | 16.51% |
Correlation
The correlation between HOOD and UTHR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jul 29, 2021 | 0.15 |
Fundamentals
HOOD:
$77.81B
UTHR:
$25.71B
HOOD:
$2.07
UTHR:
$27.00
HOOD:
41.10
UTHR:
20.17
HOOD:
0.00
UTHR:
0.66
HOOD:
19.93
UTHR:
8.19
HOOD:
8.03
UTHR:
4.36
HOOD:
$3.91B
UTHR:
$3.17B
HOOD:
$2.86B
UTHR:
$2.74B
HOOD:
$1.80B
UTHR:
$1.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HOOD vs. UTHR — Risk / Return Rank
HOOD
UTHR
HOOD vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Robinhood Markets, Inc. (HOOD) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HOOD | UTHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.16 | ||
| Sortino ratioReturn per unit of downside risk | -1.96 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.37 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 0.24 | 4.13 | -3.89 |
| Martin ratioReturn relative to average drawdown | 0.44 | 10.54 | -10.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HOOD | UTHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | 1.36 | -1.16 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.73 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.49 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.38 | -0.11 |
Drawdowns
HOOD vs. UTHR - Drawdown Comparison
The maximum HOOD drawdown since its inception was -90.21%, roughly equal to the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for HOOD and UTHR.
Loading charts...
Drawdown Indicators
| HOOD | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.21% | -93.18% | +2.97% |
Max Drawdown (1Y)Largest decline over 1 year | -57.26% | -16.35% | -40.91% |
Max Drawdown (3Y)Largest decline over 3 years | -57.26% | -33.00% | -24.26% |
Max Drawdown (5Y)Largest decline over 5 years | — | -33.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.56% | — |
Current DrawdownCurrent decline from peak | -44.22% | -8.73% | -35.49% |
Average DrawdownAverage peak-to-trough decline | -60.95% | -35.31% | -25.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.25% | 6.39% | +24.86% |
Volatility
HOOD vs. UTHR - Volatility Comparison
Robinhood Markets, Inc. (HOOD) has a higher volatility of 22.93% compared to United Therapeutics Corporation (UTHR) at 5.15%. This indicates that HOOD's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HOOD | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.93% | 5.15% | +17.78% |
Volatility (6M)Calculated over the trailing 6-month period | 50.49% | 26.01% | +24.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.17% | 49.84% | +19.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.04% | 35.13% | +38.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.04% | 35.07% | +38.97% |
Dividends
HOOD vs. UTHR - Dividend Comparison
Neither HOOD nor UTHR has paid dividends to shareholders.
Financials
HOOD vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between Robinhood Markets, Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HOOD vs. UTHR - Profitability Comparison
HOOD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Robinhood Markets, Inc. reported a gross profit of 0.00 and revenue of 359.00M. Therefore, the gross margin over that period was 0.0%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
HOOD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Robinhood Markets, Inc. reported an operating income of 0.00 and revenue of 359.00M, resulting in an operating margin of 0.0%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
HOOD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Robinhood Markets, Inc. reported a net income of 346.00M and revenue of 359.00M, resulting in a net margin of 96.4%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
Frequently Asked Questions
HOOD and UTHR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HOOD has higher volatility (22.93%) compared to UTHR (5.15%). In terms of maximum drawdown, HOOD dropped -90.21% vs UTHR's -93.18%.
UTHR currently has the higher Sharpe Ratio (1.36 vs 0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HOOD and UTHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer